0001607062-16-000655.txt : 20160212
0001607062-16-000655.hdr.sgml : 20160212
20160212161025
ACCESSION NUMBER: 0001607062-16-000655
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160209
FILED AS OF DATE: 20160212
DATE AS OF CHANGE: 20160212
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP
CENTRAL INDEX KEY: 0001059784
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 820490211
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: 33 HARBOUR SQ
STREET 2: STE 202
CITY: TORONTO ONTARIO CANADA
STATE: A1
ZIP: M5J 2G2
BUSINESS PHONE: 4163642551
MAIL ADDRESS:
STREET 1: 33 HARBOUR SQ
STREET 2: STE 202
CITY: TORONTO ONTARIO CA
STATE: A1
ZIP: M5J 2G2
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brusegard David
CENTRAL INDEX KEY: 0001516920
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-25169
FILM NUMBER: 161419139
MAIL ADDRESS:
STREET 1: 4145 NORTH SERVICE ROAD, SUITE 200
CITY: BURLINGTON
STATE: A6
ZIP: L7L6A3
4
1
brusegard021216form4.xml
FORM 4
X0306
4
2016-02-09
0
0001059784
GENEREX BIOTECHNOLOGY CORP
GNBT
0001516920
Brusegard David
4145 NORTH SERVICE ROAD, SUITE 200
BURLINGTON
A6
L7L6A3
ONTARIO, CANADA
0
1
0
0
Chief Operating Officer
Common Stock
2016-02-09
4
M
0
5583775
0.001
A
3916104
D
Common Stock Purchase Option
0.001
2016-02-09
4
M
0
546448
0
D
2012-06-20
2017-06-19
Common Stock
546448
0
D
Common Stock Purchase Option
0.001
2016-02-09
4
M
0
1928925
0
D
2013-04-01
2018-04-01
Common Stock
1928925
0
D
Common Stock Purchase Option
0.001
2016-02-09
4
M
0
595239
0
D
2013-06-06
2018-06-06
Common Stock
595239
0
D
Common Stock Purchase Option
0.001
2016-02-09
4
M
0
845492
0
D
2014-01-01
2018-10-31
Common Stock
845942
0
D
Common Stock Purchase Option
0.001
2016-02-09
4
M
0
1667671
0
A
2016-02-09
2020-10-26
Common Stock
1667671
1667671
D
/s/ Dr. David Brusegard, PhD
2016-02-09